Prize

Otto-Johannsen-Preis

Posted on

We would like to congratulate Evi Holocher on winning the prestigious Otto-Johannsen-Price of her Hochschule Reutlingen for her outstanding Bachelor-Thesis! Each year, one extraordinary Master- and Bachelor-Thesis is awarded the Otto-Johannsen-Price by the technical faculty – this year Evi was able to land the price with her thesis (“Einfluss modifizierter p38 MAPK-Inhibitoren auf verschiedene Pankreaskarzinommodelle […]

Uncategorized

Synovo Soundtrack 10k

Posted on

We are very excited to announce that we are a proud supporter of the first-ever edition of the Soundtrack 10k which will be held today in 3 months in Tübingen! We are looking forward to seeing as many runners enjoying the fast and beautiful course out there as possible! Join us for the first Synovo […]

Company life

#TeamScience

Posted on

Congratulations to Eva-Maria Holocher who just successfully defended her Bachelor Thesis (“Einfluss modifizierter p38 MAPK-Inhibitoren auf verschiedene Pankreaskarzinommodelle in Kombination mit Immun-Checkpoint-Inhibitoren”) We are extremely excited and proud that Evi will remain at Synovo and decided to join #TeamScience! She will be supporting our team with her expertise, dedication and enthusiasm. We appreciate the hard […]

Grants

Our anti-microbial program has been funded

Posted on

We announce funding for our breakthrough anti-microbial research program by the Netherlands NACTAR program from the Netherlands organization for Scientific Research (NWO). The project MDR-Phage brings together the expertise and resources from Synovo GmbH, Qualizyme Diagnostics, the  University of Twente, and the University of Amsterdam. Within the project, we will test our anti-microbial library of compounds […]

Company life

Congratulations

Posted on

Today we would like to highlight the hard work of our students and encourage them to keep on improving. We believe they are becoming amazing researchers. Special congratulations to Sabrina Zoeller on her recently finished Master thesis “Effect of modified p38 MAPK inhibitors in B16-F10 melanoma” and to Natasha Cloos, who recently submitted her Master thesis “Pharmacological Potential […]